  Abbreviations, acronyms & symbols                                                         
  ----------------------------------- --------------------------------------- --- --------- --------------------------------------
  ABG                                 = Arterial blood gases                      MAP       = Mean arterial pressure
  ACC                                 = Aortic cross-clamp                        PaCO~2~   = Partial pressure of carbon dioxide
  ACT                                 = Activated clotting time                   PAH       = Pulmonary arterial hypertension
  ASD                                 = Atrial septal defect                      PDA       = Patent ductus arteriosus
  CPAP                                = Continuous positive airway pressure       PEEP      = Peek end expiratory pressure
  CPB                                 = Cardiopulmonary bypass                    PH        = Pulmonary hypertension
  ETCO~2~                             = End-tidal CO~2~                           PO~2~     = Partial pressure of oxygen
  FiO~2~                              = Fraction of inspired oxygen               PTFE      = Polytetrafluroethylene
  ICU                                 = Intensive care unit                       RHC       = Right heart catheterization
  IS                                  = Inotropic score                           VIS       = Vasoactive inotropic score
  LCOS                                = Low cardiac output syndrome               VSD       = Ventricular septal defect

INTRODUCTION
============

In the inceptual era of pediatric cardiac surgery, prolonged mechanical ventilation was a norm in the postoperative care, which significantly contributed to morbidity and mortality. Early extubation (within 6-8 hours after surgery)^\[[@r1]\]^ following pediatric cardiac surgery was initially conceptualized in the 1980s^\[[@r2]\]^. This gradually received wide acceptance due to increasing number of patients and limited resources.

In the modern era, where chance of error tends to zero in terms of results, early extubation has improved results tremendously in appropriate cases by reducing potential complications of prolonged mechanical ventilation. This strategy reduces intensive care unit (ICU) and hospital stay, henceforth reduces overall treatment cost and utilization of resources.

In the literature, there have been relatively few articles addressing this useful strategy ^\[[@r3]-[@r10]\]^. But, despite of its advantages, it cannot be applied in all cases, as various factors decide whether early extubation is feasible or not. Therefore, we have performed a prospective observational study to identify the predictive factors for early extubation after ventricular septal defect (VSD) closure.

METHODS
=======

All consecutive patients operated for VSD closure between March 2015 and February 2016 in the Department of Cardiothoracic Surgery, U.N. Mehta Institute of Cardiology & Research Center, were enrolled in this prospective observational study. The study was approved by our institutional ethics committee and informed and written consent was obtained from the parents of all the patients. Inclusion criteria were presence of isolated or multiple VSDs, with or without atrial septal defect (ASD), and/or patent ductus arteriosus (PDA). Patients with associated complex congenital cardiac disease other than ASD and PDA and patients on ventilator preoperatively were excluded. Size of VSD was categorized echocardiographically as small, moderate or large. A large defect has a diameter of 75% or greater of the aortic annulus and ≤ 1 m/s of velocity flow by Doppler. A small defect has diameter \< 33% of aortic annulus and a flow velocity ≥ 4 m/s^\[[@r11]\]^.

Premedication and Anesthetic Management
---------------------------------------

Intravenous midazolam was used as premedication at dose 0.1 mg/kg, 15-20 minutes before induction of anesthesia. Patients were induced with intravenous fentanyl (5-10 µg/kg) and vacuronium (0.2 mg/kg). Inhalational induction with sevoflurane 8% in 100% oxygen was done in patients with no intravenous line. Maintenance anesthesia consisted of low concentration sevoflurane, intravenous fentanyl (1 µg/kg) and vacuronium 0.1 mg/kg hourly and whenever required.

Invasive blood pressure monitoring was performed through right radial or right femoral artery catheterization. Central venous pressure monitoring was performed through internal jugular vein catheterization. Other monitoring included electrocardiogram, oxygen saturation, end-tidal CO~2~ (ETCO~2~), nasopharyngeal temperature and urine output. Arterial blood gases (ABG), with haemoglobin, electrolytes, blood sugar, and activated clotting time (ACT) were also monitored. Monitoring during cardiopulmonary bypass (CPB) time included mean arterial pressure (MAP), urine output and systemic venous oxygen saturation. ABG and ACT were done half hourly while the patient was on pump.

Surgery and Cardiopulmonary Bypass
----------------------------------

All the patients were operated through midline sternotomy, moderate hypothermic cardiopulmonary bypass (temperature 32ºC) and blood cardioplegic arrest. VSD was closed with polytetrafluroethylene (PTFE) patch using continuous sutures or primarily using pledgeted sutures. Milrinone (50 µg/kg loading dose followed by 0.5 µg/kg/min infusion) and epinephrine (0.05 µg/kg/min) were used as a choice of inotropes while weaning from CPB and continued in the postoperative period. Inotropes were titrated depending upon hemodynamics. Milrinone was continued in the postoperative period at least 24 hours postextubation and gradually tapered thereafter. Before extubation, effect of muscle relaxant was reversed with glycopyrrolate (10 µg/kg) and neostigmine (0.05 mg/kg) intravenously. Postoperatively, all patients were given fentanyl infusion (1-2 µg/kg/hour) and intravenous paracetamol 15 mg/kg/dose 8 hourly for pain relief. Fentanyl infusion was continued until the patient was extubated and/or drains were removed.

Criteria for Early Extubation
-----------------------------

Patients were considered for extubation since they regained consciousness with adequate airway protective reflexes without the use of accessory respiratory muscle and if they met the following criteria: stable hemodynamics, adequate urine output, no significant mediastinal bleeding, adequate oxygenation at fraction of inspired oxygen (FiO~2~) 50% or less (pO~2~/FiO~2~ \> 200), pH 7.35 or greater, partial pressure of carbon dioxide (PaCO~2~) in arterial blood ≤ 45 mmHg or less at peek end expiratory pressure (PEEP) 5 cmH~2~O on continuous positive airway pressure (CPAP) with pressure support ≤ 8 cmH~2~O. Intensivist, anesthesiologist and surgeon jointly decide on early or delayed extubation.

To identify the risk factors for early extubation, patients were divided into two groups based on duration of mechanical ventilation: Group 1 (≤ 6 hours) and Group 2 (\> 6 hours). Both groups were compared for age, sex, weight, nutritional status, genetic disorders (*e.g.* Down syndrome), severity of pulmonary arterial hypertension (PAH), vasoactive inotropic score (VIS)^\[[@r12]\]^, type and number of VSDs, aortic cross-clamp (ACC) and CPB time, postoperative complications^\[[@r13]\]^, ICU stay, hospital stay and mortality. Definitive diagnosis of pulmonary hypertension (PH) requires an elevated mean pulmonary arterial pressure (P~pa~) of ≥ 25 mmHg at rest, measured by right heart catheterization (RHC).

Low cardiac output syndrome (LCOS) was defined as clinical signs or symptoms (tachycardia, oliguria, poor perfusion, cold extremities, hypotension, lowered level of consciousness, cardiac arrest) with or without a widened arterial-mixed venous oxygen saturation difference or metabolic acidosis ^\[[@r14],[@r15]\]^. A stroke is any confirmed neurological deficit of abrupt onset caused by a disturbance in blood flow to the brain, when the neurologic deficit does not resolve within 24 hours. Significant bleeding (12 ml/kg/h in 1^st^ hour or 10 ml/kg/h in 2^nd^ hour or 8 ml/kg/h in the 3^rd^ hour) affecting the hemodynamics or requiring re-exploration ^\[[@r16]\]^. Hematologic dysfunction was defined as platelet count \< 80,000/mm^\[[@r14]\]^ or a decline of 50% in the platelet count from the highest value recorded over the last 48 hours^\[[@r17]\]^. Hepatic dysfunction was defined as alanine transaminase level 2 times upper limit of normal. Prolonged ventilatory requirement was defined as need for invasive ventilation for more than 48 hours^\[[@r17]\]^.

Statistical Analysis
--------------------

Statistical analysis was carried out using SPSS version 20.0 software (SPSS Inc., USA). Quantitative data was expressed as mean ± SD whereas qualitative data was expressed as percentage. The *P* value less than 0.05 was considered to be significant. Univariate analysis of the continuous data using Student\'s t-test, whereas chi-square test was used for the categorical data. The variables following non-normal distribution were assessed using Mann-Whitney U test.

RESULTS
=======

Study included total 135 patients operated for VSD closure with or without ASD and/or PDA. Group 1 included 99 (73.3%) patients while Group 2 included 36 (26.7%). Demographic details of the patients are shown in [Table 1](#t1){ref-type="table"}. Mean age was 26.7 months (range 2 months to 12 years) and mean weight was 7.46 kg (range 3.4 to 25 kg). Trisomy 21 (Down syndrome) was present in 9 (6.6%) patients. One hundred and twenty (88.8%) patients had chronic malnutrition. However, mean age (26.37 months in Group 1 and 18.5 months in Group 2, *P*=0.019) was significantly more in Group 1 while incidence of trisomy 21 was significantly less (*P*=0.015) in Group 1 compared to Group 2. There was no significant difference between the two groups with regards to sex, type and size of VSD, severity of PAH and associated cardiac lesions. Incidence of multiple VSD was significantly more in Group 2 (*P*=0.019).

###### 

Demographic details.

                              Group 1 ≤ 6 hrs (n=99)   Group 2 \> 6 hrs (n=36)   *P*value
  --------------------------- ------------------------ ------------------------- ----------
  Age (months)                26.37 ± 30.89            18.5 ± 26.2               0.019
  Sex (male)                  (56.56%)                 (50%)                     0.7869
  Weight (kg)                 7.85 ± 4.14              6.38 ± 3.68               0.005
  Malnutrition                88 (87.8%)               32 (91.6%)                0.808
  Trisomy 21 (n, %)           2 (3%)                   7 (16.6%)                 0.015
  Type of VSD                                                                     
      Perimembranous (n, %)   68 (68.6%)               20 (55.5%)                0.225
      Subaortic (n, %)        19 (19.1%)               10 (27.7%)                0.402
      Muscular (n, %)         12 (12.1%)               6 (16.6%)                 0.688
  Size of VSD                                                                     
      Small VSD (n, %)        24 (25.2%)               7 (16.6%)                 0.802
      Moderate VSD (n, %)     4 (4.04%)                \_\_                      0.533
      Large VSD (n, %)        72 (70.7%)               28 (83.3%)                0.480
  PAH                                                                             
      Mild PAH (n, %)         20 (21.21%)              3 (5.5%)                  0.198
      Moderate PAH (n, %)     10 (10.10%)              3 (8.3%)                  0.931
      Severe PAH (n, %)       70 (68.68%)              29 (86.1%)                0.208
  Lesions                                                                         
      Single VSD (n, %)       80 (79.79%)              23 (66.6%)                0.139
      Multiple VSD (n, %)     5 (5.05%)                7 (19.4%)                 0.019
      VSD+PDA (n, %)          3 (3.03%)                1 (2.7%)                  0.618
      VSD+ASD (n, %)          12 (12.12%)              4 (11.1%)                 0.888

VSD=ventricular septal defect; ASD=atrial septal defect; PAH=pulmonary arterial hypertension; PDA=patent ductus arteriosus

In intraoperative data, ACC time (*P*=0.443) and CPB time (*P*=0.522) were comparable in both groups ([Table 2](#t2){ref-type="table"}). Postoperatively, VIS was significantly higher in Group 2 (*P*=0.001). Arterial blood gas data was comparable in both groups, except arterial partial pressure of oxygen (PO~2~), which was significantly higher in Group 1 (*P*=0.034). Mean duration of mechanical ventilation (4.4±0.9 hours *vs.* 25.9±24.9 hours, *P*\<0.001), ICU stay (3.1±1.3 days *vs.* 5.6±2.9 days, *P*\<0.001), and hospital stay (7.8±2.4 days *vs.* 11.2±4.9 days, *P*\<0.001) were significantly lower in Group 1 compared to Group 2.

###### 

Intraoperative and postoperative data.

                            Group 1≤ 6 hrs (n=99)   Group 2\> 6 hrs (n=36)   *P* value
  ------------------------- ----------------------- ------------------------ -----------
  ACC time (min)            28.45±11.18             31.30±14.91              0.443
  CPB time (min)            46.75±13.84             50.91±19.53              0.522
  VIS                       9.01±2.05               10.65±2.94               0.001
  Arterial blood gas                                                          
      pH                    7.38±0.04               7.38±0.07                0.937
      PCO~2~ (mmHg)         38.29±5.78              38.20±7.9                0.978
      PO~2~ (mmHg)          246.57±79.28            207.98±82.52             0.034
      Hematocrit (%)        39.26±5.94              37.08±6.86               0.057
      Bicarbonate (mEq/L)   26.24±24.82             22.85±3.12               0.893
  MVT (hours)               4.4±0.9                 25.9±24.9                \<0.001
  ICU stay (days)           3.1±1.3                 5.6±2.9                  \<0.001
  Hospital stay (days)      7.8±2.4                 11.2±4.9                 \<0.001

ACC=aortic cross-clamp; CPB=cardiopulmonary bypass; VIS=vasoactive inotropic score; PCO2=partial pressure of carbon dioxide; PO2=partial pressure of oxygen; MVT=mechanical ventilation time; ICU=intensive care unit

Reintubation was required in 6 patients, of which 2 patients were in Group 1. Incidence of reintubation and postoperative complications, including transient heart block, LCOS, sepsis, significant bleeding and neurological events was greater in Group 2. However, the difference was not statistically significant except for LCOS ([Table 3](#t3){ref-type="table"}). Incidence of LCOS was significantly higher in Group 2 (*P*\<0.001). There was one death in Group 2 due to LCOS and no deaths in Group 1, however the difference was not statistically significant (*P*=0.596). Regression analysis is shown in [Table 4](#t4){ref-type="table"}. Regression analysis found independent association of trisomy 21 (OR: 0.248; 95% CI: 0.176-0.701; *P*=0.001), multiple VSD (OR: 0.243; 95% CI: 0.147-0.606; *P*=0.002), VIS score (OR: 0.174; 95% CI: 0.002-0.062; *P*=0.039) and LCOS (OR: 0.291; 95% CI: 0.267-0.979; *P*=0.001) with late extubation. LCOS and trisomy 21 were the strongest predictor of late extubation, closely followed by multiple VSD and the least was VIS ([Table 4](#t4){ref-type="table"}).

###### 

Postoperative complications and mortality.

                                     Group 1≤ 6 hrs (n=99)   Group 2\>6 hrs (n=36)   *P*value
  ---------------------------------- ----------------------- ----------------------- ----------
  Reintubation                       2 (2%)                  4 (11.1%)               0.072
  LCOS                               0                       6 (16.6%)               \<0.001
  Heart block                                                                         
      Transient                      \_\_                    3                        
      Permanent                      \_\_                    \_\_                     
  Renal dysfunction                  \_\_                    \_\_                     
  Hepatic dysfunction                \_\_                    \_\_                     
  Respiratory failure                \_\_                    \_\_                     
  Haematological complication        \_\_                    \_\_                     
  Prolonged mechanical ventilation   \_\_                    \_\_                     
  Sepsis                             6 (6%)                  2 (5.5%)                0.762
  Bleeding                           \_\_                    1 (2.7%)                0.596
  Neurological event                 \_\_                    1 (2.7%)                0.596
  Mortality                          \_\_                    1 (2.7%)                0.596

LCOS=low cardiac output syndrome

###### 

Regression analysis.

                 Unstandardized coefficients   Standardized coefficients            95% Confidence Interval for B                    
  -------------- ----------------------------- --------------------------- -------- ------------------------------- ------- -------- -------
  (Constant)     0.199                         0.193                                1.030                           0.305   -0.184   0.582
  Age (month)    0.003                         0.003                       0.200    1.164                           0.247   -0.002   0.008
  Weight         -0.028                        0.019                       -0.261   -1.526                          0.130   -0.065   0.008
  PO~2~          -0.001                        0.000                       -0.144   -1.915                          0.058   -0.002   0.000
  Trisomy 21     0.438                         0.133                       0.248    3.303                           0.001   0.176    0.701
  Multiple VSD   0.376                         0.116                       0.243    3.240                           0.002   0.147    0.606
  VIS            0.032                         0.015                       0.174    2.090                           0.039   0.002    0.062
  Transient HB   0.211                         0.267                       0.071    0.790                           0.431   -0.318   0.740
  LCOS           0.623                         0.180                       0.291    3.462                           0.001   0.267    0.979

VSD=ventricular septal defect; PO~2~=partial pressure of oxygen; VIS=vasoactive inotropic score; HB=heart block; LCOS=low cardiac output syndrome

DISCUSSION
==========

Advances in surgical and anaesthetic techniques have facilitated early extubation following paediatric cardiac surgery. Early extubation has led to decreased cardiac and respiratory morbidity, lower rate of nosocomial pneumonia, reduction in overall length of hospital stay and decreased cost of patient care^\[[@r8],[@r18]-[@r20]\]^. Reintubation rate following early extubation is also reported to be very low (\< 2-3%)^\[[@r21]\]^.

In our study, 74.1% patients were successfully extubated within 6 hours of surgery and mean duration of mechanical ventilation was 4.4±0.9 hours, while only 2% patients require reintubation after early extubation. These results are consistent with various studies. In the studies by Mittnacht et al.^\[[@r20]\]^ and Akhtar et al.^\[[@r17]\]^, 76% patients operated for VSD closure were successfully extubated early. Our results along with results of their studies show that with appropriate perioperative management, about 75% patients can be extubated early after VSD closure without significant increase in risk of reintubation.

In our study, on univariate analysis, age, weight, trisomy 21, multiple VSDs, high VIS, low PO~2~ and low cardiac output after surgery were significant risk factors for delayed extubation. However, on multivariate analysis, trisomy 21, multiple VSD, VIS score and LCOS after surgery were found to be independently associated with delayed extubation.

Patients who are operated for multiple, VSDs have higher risk of residual defect and ventricular dysfunction postoperatively, leading to increased mortality and morbidity^\[[@r23]\]^. Therefore, these patients are at higher risk for prolonged ventilation as seen in our study. Mean ventilation duration in these patients was significantly higher (13.7±8.5 hours *vs.* 4.4±0.9 hours) compared to patients with single VSD, despite having zero percent incidence of postoperative residual defect or ventricular dysfunction. However, we were able to extubate early 5 (41.6%) of the 12 patients with multiple VSDs. We feel that, although presence of multiple VSDs increases the risk of prolonged ventilation, it should not be taken as a contraindication to early extubation. Carefully selected patients with multiple VSDs can still be extubated early.

In our study, 9 (6.7%) patients had trisomy 21. Seven out of 9 patients had delayed extubation, however ACC and CPB time were comparable in patients with or without trisomy 21 (29.3±12.4 *vs.* 29.2±12.3, *P*=0.98 and 48±15.7 *vs.* 47.9±15.6, *P*=0.98 respectively). Of these 9 patients, none developed LCOS postoperatively. Our results are in congruence with Mittnacht et al.^\[[@r20]\]^. Studies have found that patients with trisomy 21 are at high risk for atelectasis and pneumonia^\[[@r20],[@r21]\]^. We could not find any reason for prolonged intubation in these patients in our study.

LCOS was another significant risk factor for delayed extubation in our study. Shi et al.^\[[@r7]\]^, in their retrospective review of 172 infants operated for cardiac surgery, found that LCOS is an independent risk factor for prolonged ventilation and increased mortality. In our study, patients with LCOS had significantly increased duration of ventilation (45.5±57.0 hrs) as compared to patients without LCOS (8.15±7.91 hrs). Studies have also found that positive pressure ventilation is helpful in patients with LCOS by decreasing work of breathing, improving systemic oxygen delivery and by improving cardiac performance. Thus, positive pressure ventilation act as an important hemodynamic support in postoperative systolic ventricular dysfunction^\[[@r20],[@r23]\]^. Studies have also shown that greater inotropic score (IS) and VIS are signiﬁcantly associated with delayed extubation and extubation failure^\[[@r1],[@r18],[@r21],[@r23],[@r24]\]^ due to associated hemodynamic instability^\[[@r16]\]^. Our results are comparable to studies in literature.

Various studies have found age, ACC time and CPB time as independent risk factors for delayed extubation^\[[@r1],[@r8],[@r26]\]^; however, in our study, age, weight, sex, ACC time, CPB time, size of VSD, preoperative pulmonary hypertension and presence of malnutrition were not significant risk factor for delayed extubation. The possible mechanism given for these were mainly respiratory complications leading to delayed extubation. Literature has shown that CPB time \> 150 minutes has been found to be a significant risk factor for delayed extubation^\[[@r1]\]^, but in our study maximum CPB time was only 98 minutes, so the chances of pump related respiratory complications were lower. In their study, age \< 6 months was strongly associated with delayed extubation, which was not the case in our study^\[[@r1]\]^.

Many studies have also found young age as an independent risk factor for delayed extubation after paediatric cardiac surgery^\[[@r1],[@r8],[@r18],[@r19]\]^. The reasons cited for this are poor fatigue resistance and endurance of respiratory muscles and immature respiratory centre with poor response to hypoxia and hypercarbia^\[[@r18],[@r19]\]^. Many other factors responsible for delayed extubation are low body weight, malnutrition, frequent infections and depressed immunity^\[[@r10],[@r20],[@r25],[@r26]\]^. However, most of recent studies, including ours, have failed to find age related risk factors significant for delayed extubation^\[[@r2],[@r27]\]^. Mittnacht et al.^\[[@r20]\]^ in their study extubated patients as young as 2 months. The authors found that other risk factors, in association with young age, increased the risk of delayed extubation rather than age alone. Moreover, authors commented that it is the resistance of anaesthetist and intensivist rather than age of the patient, which is responsible for delay in extubation in young patients.

Earlier, preoperative PAH was considered a major limiting factor for early extubation^\[[@r8],[@r21],[@r28]\]^ due to risk of pulmonary hypertensive crisis. However, recent studies have found early extubation to be helpful in these patients by reduced airway irritation and ventilator-associated complications, such as laryngotracheal trauma, pulmonary hypertensive crisis during endotracheal tube suctioning, mucous plugging of endotracheal tubes, barotrauma secondary to positive airway pressure ventilation, ventilator-associated pulmonary infections and atelectasis^\[[@r30]-[@r31]\]^. Herein, we also did not find preoperative PAH as a risk factor for delayed extubation, comparable to study by Vida et al.^\[[@r29]\]^.

We found that early extubation translates into significantly reduced ICU stay and hospital stay without increasing the risk of reintubation or mortality, similar to results of various studies ^\[[@r3]-[@r10]\]^. This not only helps in early mobilisation of the patient and reduces parental anxiety, but also reduces the cost of patient care and provides better utilisation of limited hospital resources.

We believe that the most important determinant for successful early extubation is the approach to all the patients as potential candidates for early extubation and then to optimize the perioperative events to achieve this goal. When treated in this manner, even neonates and young infants operated for VSD closure can be successfully extubated early.

CONCLUSION
==========

Every child with VSD closure is a potential candidate of early extubation. Early extubation after VSD closure is successful in the majority of infants and small children without increasing the risk of reintubation or mortality. The strongest independent risk factors delayed extubation are trisomy 21, LCOS, multiple VSDs and high VIS.

  Authors\' roles & responsibilities   
  ------------------------------------ -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  DP                                   Substantial contributions to the conception or design of the work; acquisition, analysis, or interpretation of data for the work; final approval of the version to be published
  KL                                   Revising the work critically for important intellectual content; final approval of the version to be published
  PG                                   Substantial contributions to the conception or design of the work; acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published
  KP                                   Acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published
  RS                                   Substantial contributions to the conception or design of the work; final approval of the version to be publisheda
  JS                                   Revising the work critically for important intellectual content; final approval of the version to be published
  JP                                   Analysis, or interpretation of data for the work; final approval of the version to be published
  HP                                   Interpretation of data for the work; final approval of the version to be published

No conflict of interest.

This study was carried out at the U. N. Mehta Institute of Cardiology and Research Center (affiliated to BJ Medical College, Ahmedabad), Gujarat, India.

No financial support.
